All Stories

  1. Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease
  2. Medicine use in pregnancy and public cord blood bank databases
  3. CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence
  4. Primary myelofibrosis: when the clone manifests with Rh phenotype splitting
  5. Use of allogenic umbilical cord blood for red cells transfusion in premature infants: utopia or reality?
  6. P-236 Endothelial progenitor cells in MDS patients show specific genetic signatures and abnormal cytokine production which could contribute to myelodysplastic hematopoiesis
  7. Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people
  8. Mantle cell lymphoma relapsing at the lymphedematous arm.
  9. Blood and endothelial cells: together through thick and thin
  10. Proangiogenic Hematopoietic Cells In Acute HIV Infection
  11. Endothelial Progenitor Cells in HIV-Positive Patients
  12. CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.
  13. Does "more" necessarily mean "better"?
  14. von Hippel-Lindau Disease and Erythrocytosis
  15. Endothelial progenitor cells and thrombosis
  16. Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
  17. Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young type 3
  18. Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome
  19. Cauda equina enhancing lesion in a HIV-positive patient. Case report and literature revision.
  20. Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome
  21. Advances in understanding the pathogenesis of familial thrombocythaemia
  22. Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms
  23. Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma
  24. Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons
  25. Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma
  26. Thrombopoietin Receptor Activation, Thrombopoietin Mimetic Drugs, and Hereditary Thrombocytosis: Remarks on Bone Marrow Fibrosis
  27. 44 High dose methotrexate followed by temozolomide plus concomitant radiation therapy in patients with newly diagnosed primary central nervous system Lymphoma: Preliminary results of a phase I dose escalation study
  28. Essential thrombocythemia as underlying cause of malabsorption syndrome
  29. Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative
  30. Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis
  31. Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia
  32. The mutantJAK2V617Fallele burden in children with essential thrombocythemia
  33. Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review
  34. COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
  35. Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative
  36. Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases
  37. Phosphorylated STAT5 Represents a New Possible Prognostic Marker in Hodgkin Lymphoma
  38. Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?
  39. A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis
  40. The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia
  41. Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation
  42. Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia
  43. Blastoid Mantle Cell Lymphoma Occurring in a Patient in Complete Remission of Chronic Myelogenous Leukemia
  44. The PRV-1 gene expression in essential thrombocythemia
  45. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS
  46. Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis
  47. Overexpression of the Polycythemia Rubra Vera-1 Gene in Essential Thrombocythemia
  48. The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia
  49. Expression of p15ink4b gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors
  50. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
  51. Expression of cyclin-dependent kinase inhibitor p15INK4B during normal and leukemic myeloid differentiation
  52. Short term treatment withEscheria coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease
  53. Spontaneous Erythroid Colony Formation as the Clue to an Underlying Myeloproliferative Disorder in Patients with Budd-Chiari Syndrome or Portal Vein Thrombosis
  54. Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: Role of heat-shock protein-70
  55. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist
  56. Hodgkin's lymphoma in a cyclist treated with growth hormone
  57. Quercetin and the Growth of Leukemic Progenitors
  58. Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis
  59. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34± haematopoietic progenitor cells
  60. Evaluation of a Novel Automated Protocol for the Collection of Peripheral Blood Stem Cells Mobilized with Chemotherapy or Chemotherapy Plus G-CSF Using the Fresenius AS104 Cell Separator
  61. Effect of all-transretinoic acid on procoagulant activity of promyelocytic blast cells in culture
  62. Autologous Bone Marrow Transplantation with Peripheral Stem Cells In vivo Expanded by Chemotherapy and G-CSF
  63. An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression
  64. Acute onset of juvenile myelodysplastic syndrome mimicking thrombotic thrombocytopenic purpura and rapidly evolving in overt myeloid leukemia
  65. Effects of a preformed extracellular matrix on long-term serum-free bone marrow culture
  66. DISAPPEARANCE OF SPONTANEOUS ERYTHROID COLONIES IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS TREATED BY ALPHA-INTERFERON
  67. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth
  68. L-Asparaginase-Induced Coagulopathy in Acute Lymphoblastic Leukemia
  69. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors
  70. Arterial thrombosis as clinical manifestation of congenital protein C deficiency
  71. Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient italian family
  72. Ultrasound-Doppler Diagnosis of Budd-Chiari Syndrome
  73. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids
  74. Mesenteric vein thrombosis in protein S congenital deficiency
  75. Evaluation of Myelotoxic Effects in Non-Hodgkin’s Lymphomas Treated with Interferon-α and Chlorambucil
  76. ASSOCIATION OF CONGENITAL PROTEIN C DEFICIENCY AND LATENT MYELOPROLIFERATIVE DISEASE AS CAUSE OF SPLANCHNIC VENOUS THROMBOSIS IN A 34-YEAR-OLD WOMAN
  77. Transient ischemic attack in a patient with congenital protein-c deficiency during treatment with stanozolol
  78. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients
  79. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients
  80. Cerebrospinal fluid beta-2-microglobulin: A reliable index of leukaemic infiltration of central nervous system
  81. Overexpression of <I>PRV-1</I> Gene in Polycythemia Rubra Vera and Essential Thrombocythemia